palmidrol has been researched along with Seizures in 3 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Latency to induce seizure, seizure stages and latency and duration of fifth stage of seizure was recorded for each animal." | 1.42 | Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors. ( Aghaei, I; Babaei, P; Khakpour-Taleghani, B; Motamedi, F; Naderi, N; Rostampour, M; Shabani, M, 2015) |
| "When tested against PTZ-induced convulsions, PEA protected against tonic convulsions and prolonged the latency between convulsive episodes." | 1.32 | Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid. ( Corcoran, ME; Saucier, DM; Sheerin, AH; Zhang, X, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghaei, I | 1 |
| Rostampour, M | 1 |
| Shabani, M | 1 |
| Naderi, N | 1 |
| Motamedi, F | 1 |
| Babaei, P | 1 |
| Khakpour-Taleghani, B | 1 |
| Sheerin, AH | 1 |
| Zhang, X | 1 |
| Saucier, DM | 1 |
| Corcoran, ME | 1 |
| Lambert, DM | 1 |
| Vandevoorde, S | 1 |
| Diependaele, G | 1 |
| Govaerts, SJ | 1 |
| Robert, AR | 1 |
3 other studies available for palmidrol and Seizures
| Article | Year |
|---|---|
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors.
Topics: Amides; Animals; Anticonvulsants; Disease Models, Animal; Ethanolamines; Kindling, Neurologic; Male; | 2015 |
Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid.
Topics: Amides; Amygdala; Animals; Cannabinoid Receptor Modulators; Cannabinoids; Dimethyl Sulfoxide; Dose-R | 2004 |
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.
Topics: Amides; Animals; Anticonvulsants; Cannabinoid Receptor Modulators; Cannabinoids; Convulsants; Diseas | 2001 |